We are live on ! Find out more
ZURAW

Zura Bio Limited Warrants

Delisted

ZURAW was delisted on the 27th of August, 2024.

14 hedge funds and large institutions have $619K invested in Zura Bio Limited Warrants in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more funds holding

Funds holding: 1114 (+3)

10% more capital invested

Capital invested by funds: $561K → $619K (+$57.3K)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
5
Closed
Calls
$365K
Puts
Net Calls
+$365K
Net Calls Change
-$159K

ZURAW Hedge Fund Activity: Q4 2023 in Review

14 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q4 2023, worth a combined $619K — up 10% from $561K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ZURAW positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 5 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $86.3K. The largest seller was AQR Arbitrage, cutting an estimated $2.03K.

  • 14 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q4 2023, up from 11 in Q3 2023.
  • Funds reported $619K of Zura Bio Limited Warrants stock for Q4 2023, up 10% quarter-over-quarter.
  • 3 funds opened new Zura Bio Limited Warrants positions in Q4 2023 and 0 closed out, a net change of +3 holders.
  • The largest Zura Bio Limited Warrants buyer in Q4 2023 was Hudson Bay Capital Management, an estimated $86.3K added.
  • The largest Zura Bio Limited Warrants seller in Q4 2023 was AQR Arbitrage, an estimated $2.03K sold.

Based on aggregated 13F filings for Q4 2023.